+ All Categories
Home > Documents > BD MAX MRSA XT · TOTAL 160 2192 2352 Sensitivity: 93.1% Specificity: 97.5% BD MAX™ MRSA XT...

BD MAX MRSA XT · TOTAL 160 2192 2352 Sensitivity: 93.1% Specificity: 97.5% BD MAX™ MRSA XT...

Date post: 26-Apr-2020
Category:
Upload: others
View: 4 times
Download: 0 times
Share this document with a friend
2
BD MAX MRSA XT with eXTended Detection Technology for Newly Discovered MRSA Strains INTRODUCING BD MAX MRSA XT A better assay design for better patient safety at lower healthcare costs • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • HAI Reduce the risk of transmission due to new and emerging strains of MRSA - New MREJ types, not detected by other molecular assays 1 - MRSA strains with the novel mecC gene, account for 3 to 4% of all cases 2 Avoid cost and patient impact associated with unnecessary isolation and treatment due to mecA dropouts - Up to 18% of all positive MRSA results, reported by other molecular assays, may actually be false positives 3,4,5 - Patients wrongly identified as carriers may acquire MRSA when cohorted with true carriers 4
Transcript
Page 1: BD MAX MRSA XT · TOTAL 160 2192 2352 Sensitivity: 93.1% Specificity: 97.5% BD MAX™ MRSA XT performance compared to Combined (direct and enriched) Culture for MRSA1 Product Description

BD MAX™ MRSA XTwith eXTended Detection Technology for Newly Discovered MRSA Strains

INTRODUCING

BD MAX™ MRSA XTA better assay design for better patient safety at lower healthcare costs

• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •HAI

• Reduce the risk of transmission due to new and emerging strains of MRSA

- New MREJ types, not detected by other molecular assays1

- MRSA strains with the novel mecC gene, account for 3 to 4% of all cases2

• Avoid cost and patient impact associated with unnecessary isolation and treatment due to mecA dropouts

- Up to 18% of all positive MRSA results, reported by other molecular assays, may actually be false positives3,4,5

- Patients wrongly identified as carriers may acquire MRSA when cohorted with true carriers4

Page 2: BD MAX MRSA XT · TOTAL 160 2192 2352 Sensitivity: 93.1% Specificity: 97.5% BD MAX™ MRSA XT performance compared to Combined (direct and enriched) Culture for MRSA1 Product Description

BD DiagnosticsTullastrasse 8-1269126, Heidelberg,Germanywww.bd.com/europe/ds

For more information, please contact [email protected] or visit our website: www.bd.com/europe/ds

1 Data on File

2 Petersen et al., Epidemiology of methicillin-resistant Staphylococcus aureus carrying the novel mecC gene in Denmark corroborates a zoonotic reservoir with transmission to humans Clin Micro Infect 2013; 19:E16-E22

3 Arbefeville et al. Prevalence and Genetic Relatedness of Methicillin-Susceptible Staphylococcus aureus Isolates Detected by the Xpert MRSA Nasal Assay J. Clin. Microbiol. 2011; 49:2996-2999

4 Blanc et al., High Proportion of Wrongly Identified Methicillin-Resistant Staphylococcus aureus Carriers by Use of a Rapid Commercial PCR Assay Due to Presence of Staphylococcal Cassette Chromosome Element Lacking the mecA Gene J. Clin. Microbiol. 2011; 49:722-724

5 Farley et al., Comparison of the BD GeneOhm Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Assay to Culture by Use of BBL CHROMagar MRSA for Detection of MRSA in Nasal Surveil-lance Cultures from an At-Risk Community Population J. Clin. Microbiol. 2008; 46:743-746

BD, BD Logo and BD MAX are trademarks of Becton, Dickinson and Company. © 2013 BD XEUR5243-13 Printed in Europe November 2013

Simple Efficient Workflow

• Results in about 2 hours, compared to 2-4 days for culture

• Combine MRSA XT testing in the same run as StaphSR, Cdiff and other assays

&

BD MAX™ MRSA XT

PERFORMANCE

BD MAX™ MRSA XT

CULTURE

PCR POS NEG TOTAL

POS 149 54 203

NEG 11 2138 2149

TOTAL 160 2192 2352

Sensitivity: 93.1% Specificity: 97.5%

BD MAX™ MRSA XT performance compared to Combined (direct and enriched) Culture for MRSA1

Product Description

BD MAX™ MRSA XT (24 tests)

BD MAX™ PCR Cartridges

Catalog Number

443461

437519

LOAD GOand

S IMPLY

SNAP

RegulatoryStatus*

CE-IVD

CE-IVD

* CE-IVD: CE marked in compliance with the European In Vitro Diagnostic Medical Device Directive 98/79/EC


Recommended